UPR.IR

Uniphar plc [UPR.IR] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

UPR.IR Stock Summary

Earnings have grown 23.3% per last year.

Earnings are expected to fall -100% next year

EPS has been decreasing for the past 3 years (Yearly statements)

UPR.IR has less than 1 year of cash runway

Debt-to-Equity ratio of 1.15 is considered moderate, deeper research suggested.

Top 10 Correlated Stocks

UPR.IR

In the News

UPR.IR Financial details

Company Rating

Buy

Market Cap

765.71M

Income

28.27M

Revenue

2.15B

Book val./share

Cash/share

Dividend

0.02

Dividend %

0.7%

Employees

Optionable

Shortable

Yes

Earnings

27 Feb 2024

P/E

14.95

Forward P/E

PEG

-4.46

P/S

0.33

P/B

2.35

P/C

P/FCF

10.85

Quick Ratio

0.24

Current Ratio

0.99

Debt / Equity

1.15

LT Debt / Equity

1.05

EPS (TTM)

0.11

EPS next Y

EPS next Q

EPS this Y

-5.88%

EPS next Y

EPS next 5Y

EPS last 5Y

7.78%

Revenue last 5Y

8.92%

Revenue Q/Q

EPS Q/Q

SMA20

SMA50

SMA100

50%

Inst Own

Inst Trans

ROA

ROE

17%

ROC

0.08%

Gross Margin

15%

Oper. Margin

Profit Margin

Payout

10%

Shs Outstand

Shs Float

Target Price

52W Range

1.98-3.44

52W High

-13%

52W Low

+161%

RSI

Rel Volume

0.58

Avg Volume

251.93K

Volume

145.81K

Perf Week

-5.43%

Perf Month

-1.88%

Perf Quarter

24.29%

Perf Half Y

21.4%

Beta

0.756

Volatility

0.06%, 0.06%

Prev Close

0.38%

Price

2.61

Change

2.76%

UPR.IR Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	9.07	6.95	7.2	7.6	9.35
Net income per share	0.11	0.11	0.18	0.17	0.16
Operating cash flow per share	0.58	0.25	0.19	0.3	0.19
Free cash flow per share	0.55	0.19	0.14	0.23	0.08
Cash per share	0.62	0.23	0.29	0.38	0.31
Book value per share	0.99	0.77	0.93	1.06	1.22
Tangible book value per share	-0.52	-0.66	-0.72	-0.8	-0.84
Share holders equity per share	0.99	0.77	0.93	1.06	1.22
Interest debt per share	1.03	0.85	0.94	1.19	1.48
Market cap	223.93M	624.6M	1.35B	844.93M	734.41M
Enterprise value	292.43M	782.65M	1.52B	1.06B	1.03B
P/E ratio	10.65	22.45	28.05	18.53	16.39
Price to sales ratio	0.13	0.34	0.69	0.41	0.29
POCF ratio	2.09	9.47	25.85	10.2	13.99
PFCF ratio	2.23	12.43	35.73	13.43	35.73
P/B Ratio	1.24	3.09	5.36	2.92	2.21
PTB ratio	1.24	3.09	5.36	2.92	2.21
EV to sales	0.18	0.43	0.78	0.51	0.4
Enterprise value over EBITDA	5.01	11.78	17.59	12.98	9.1
EV to operating cash flow	2.73	11.86	29.06	12.75	19.63
EV to free cash flow	2.91	15.58	40.16	16.79	50.14
Earnings yield	0.09	0.04	0.04	0.05	0.06
Free cash flow yield	0.45	0.08	0.03	0.07	0.03
Debt to equity	1.01	1.08	0.98	1.09	1.15
Debt to assets	0.24	0.26	0.26	0.28	0.3
Net debt to EBITDA	1.17	2.38	1.94	2.6	2.62
Current ratio	1.03	0.88	0.92	0.99	0.88
Interest coverage	6.15	6.81	6.52	5.72	3.07
Income quality	3.23	1.41	0.88	1.19	0.68
Dividend Yield	0	0	0	0.01	0.01
Payout ratio	0	0.07	0.12	0.1	0.11
Sales general and administrative to revenue	0.05	0.06	0.08	0.09	0.09
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.36	0.45	0.47	0.46	0.44
Capex to operating cash flow	-0.06	-0.24	-0.28	-0.24	-0.61
Capex to revenue	0	-0.01	-0.01	-0.01	-0.01
Capex to depreciation	-0.35	-0.79	-0.54	-0.7	-0.9
Stock based compensation to revenue	0	0	0	0	0
Graham number	1.6	1.36	1.93	2	2.12
ROIC	0.07	0.06	0.06	0.06	0.07
Return on tangible assets	0.04	0.06	0.1	0.08	0.06
Graham Net	-1.78	-1.67	-1.71	-1.95	-2.85
Working capital	10.89M	-42.19M	-29.71M	-6.43M	-66.03M
Tangible asset value	-95.04M	-171.96M	-194.37M	-217.66M	-228.03M
Net current asset value	-220.65M	-331.35M	-349.44M	-393.84M	-448.01M
Invested capital	1.01	1.08	0.98	1.09	1.15
Average receivables	78.74B	113.54M	118.89M	135.76M	71.03M
Average payables	285.7M	321.81M	345.37M	382.42M	353.2M
Average inventory	89M	106.84M	113.94M	134.98M	171.1M
Days sales outstanding	26.03	21.68	24.32	25.04	0
Days payables outstanding	76.33	75.68	78.23	84.26	50.48
Days of inventory on hand	24.12	26.26	24.57	32.62	31.14
Receivables turnover	14.02	16.84	15.01	14.58	0
Payables turnover	4.78	4.82	4.67	4.33	7.23
Inventory turnover	15.13	13.9	14.86	11.19	11.72
ROE	0.12	0.14	0.19	0.16	0.13
Capex per share	-0.04	-0.06	-0.05	-0.07	-0.12

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric	2022-06-30	2022-12-31	2023-03-31	2023-06-30	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	1.82	0	2.27	2.27	0
Net income per share	0.03	0	0.03	0.03	0
Operating cash flow per share	0.02	0	-0.02	-0.02	0
Free cash flow per share	0	0	-0.04	-0.04	0
Cash per share	0.25	0	0.2	0.2	0
Book value per share	0.97	0	1.11	1.11	0
Tangible book value per share	-0.73	0	-0.9	-0.9	0
Share holders equity per share	0.97	0	1.11	1.11	0
Interest debt per share	0.95	0	0.8	1.36	0
Market cap	789.68M	0	813.38M	813.38M	0
Enterprise value	980.95M	211.45M	757.72M	1.13B	296.34M
P/E ratio	24.58	0	27.09	27.09	0
Price to sales ratio	1.59	0	1.31	1.31	0
POCF ratio	147.49	0	-125.17	-125.17	0
PFCF ratio	898.38	0	-71.35	-71.35	0
P/B Ratio	3	0	2.68	2.68	0
PTB ratio	3	0	2.68	2.68	0
EV to sales	1.98	0	1.22	1.82	0
Enterprise value over EBITDA	51.68	0	38.07	56.79	0
EV to operating cash flow	183.22	0	-116.61	-173.94	0
EV to free cash flow	1.12K	0	-66.46	-99.14	0
Earnings yield	0.01	0	0.01	0.01	0
Free cash flow yield	0	0	-0.01	-0.01	0
Debt to equity	0.99	1.09	0.71	1.23	1.15
Debt to assets	0.26	0.28	0.18	0.31	0.3
Net debt to EBITDA	10.08	0	-2.8	15.92	0
Current ratio	0.95	0.99	0.95	0.95	0.88
Interest coverage	0	0	0	0	0
Income quality	0.67	0	-0.87	-0.87	0
Dividend Yield	0	0	0	0	0
Payout ratio	0.19	0	0.21	0.21	0
Sales general and administrative to revenue	0.08	0	0.09	0.09	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.47	0.46	0.46	0.46	0.44
Capex to operating cash flow	-0.84	0	0.75	0.75	0
Capex to revenue	-0.01	0	-0.01	-0.01	0
Capex to depreciation	-0.64	0	-0.63	-0.63	0
Stock based compensation to revenue	0	0	0	0	0
Graham number	0.8	0	0.83	0.83	0
ROIC	0.02	0	0.03	0.02	0
Return on tangible assets	0.02	0	0.01	0.01	0
Graham Net	-1.7	0	-2.18	-2.18	0
Working capital	-18.62M	-6.43M	-23.77M	-23.77M	-66.03M
Tangible asset value	-197.63M	-217.66M	-246.6M	-246.6M	-228.03M
Net current asset value	-355.79M	-393.84M	-452.9M	-452.9M	-448.01M
Invested capital	0.99	1.09	0.71	1.23	1.15
Average receivables	0	0	188.83M	213.66M	0
Average payables	0	0	421.11M	435.02M	0
Average inventory	0	0	166.56M	175.47M	0
Days sales outstanding	30.13	0	31.03	31.03	0
Days payables outstanding	78.75	0	74.46	74.46	0
Days of inventory on hand	27.53	0	30.04	30.04	0
Receivables turnover	2.99	0	2.9	2.9	0
Payables turnover	1.14	0	1.21	1.21	0
Inventory turnover	3.27	0	3	3	0
ROE	0.03	0	0.02	0.02	0
Capex per share	-0.02	0	-0.02	-0.02	0

UPR.IR Dividend History

UPR.IR Frequently Asked Questions

What is Uniphar plc stock symbol ?

Uniphar plc is a IE stock and trading under the symbol UPR.IR

What is Uniphar plc stock quote today ?

Uniphar plc stock price is $2.61 today.

Is Uniphar plc stock public?

Yes, Uniphar plc is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 251.93K
Market Capitalization 765.71M
Employee 3K
CEO Mr. Gerard Rabbette B.Comm FCA
Headquarters Dublin,IE
IPO Date 2019-07-17
Website https://www.uniphar.ie

Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, and internationally. The company operates through three divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail. The Commercial & Clinical division offers outsourced sales, marketing, and multichannel account management services to pharmaco-medical manufacturers; and distribution and support services to medical device manufacturers. The Product Access division provides on demand services, which provides access to pharmaco-medical products and treatments by developing valuable relationships and interactions between manufacturers and other healthcare stakeholders; and exclusive access services that offers bespoke distribution partnerships to pharmaceutical partners for key brands. The Supply Chain & Retail division engages in pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons; and operates a network of pharmacies under the Life, Allcare, and Hickey's brands. It also offers pharmacy support, pharmaceutical supply chain, specialist nursing and infusion, medical device distribution, healthcare technology, data intelligence and consultancy services, pharmaceutical advisory, medical affairs, and online pharmacy and product fostering services, as well as data solutions for pharma industry. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland.